Biogen inc stock.

The following ETFs maintain exposure to Biogen Inc. ( BIIB ). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.Biogen Inc. Common Stock (BIIB) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Biogen Inc (BIIB) stock has risen 2.66% while the S&P 500 has fallen -0.49% as of 11:16 AM on Wednesday, Apr 5. BIIB has gained $7.31 from the previous closing price of $275.25 on volume of 296,402 shares. Over the past year the S&P 500 is lower by -9.83% while BIIB has gained 36.10%. BIIB earned $20.87 a per share in the over the last 12 ...Jul 28, 2023 · Biogen to host investor conference call today at 9:00 a.m. ET. CAMBRIDGE, Mass. and PLANO, Texas, July 28, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Reata Pharmaceuticals, Inc. (Nasdaq: RETA) today announced the companies have entered into a definitive agreement under which Biogen has agreed to acquire Reata for $172.50 per share ...

Sep 25, 2023 · Biogen Inc. (BIIB) closed at $255.02 in the latest trading session, marking a -1.03% move from the prior day. This move lagged the S&P 500's daily gain of 0.4%. Meanwhile, the Dow gained 0.13% ...

Biogen Inc stock performance at a glance. Check Biogen Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. Oct 2, 2023 · BIIB stock, the ticker symbol for Biogen Inc, experienced a positive performance on October 2, 2023, based on the information provided by CNN Money. The 27 analysts who offered 12-month price forecasts for Biogen Inc had a median target of $330.00, with a high estimate of $436.00 and a low estimate of $269.00. According to the current consensus ...

Sep 12, 2023 · In the latest trading session, Biogen Inc. (BIIB) closed at $258.44, marking a -0.19% move from the previous day. This change was narrower than the S&P 500's 0.57% loss on the day. Biogen Inc. (BIIB) closed the most recent trading day at $266.15, moving -0.66% from the previous trading session. This change lagged the S&P 500's 1.3% gain on the day. Meanwhile, the Dow gained ...Mar 16, 2023 · Biogen ’s BIIB stock has risen 28.8% in the past year against a decrease of 12.3% for the industry. Biogen is facing multiple challenges. Most of its key drugs are facing declining sales. Biogen ... U.S. regulators on Monday approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's disease despite controversy over whether the clinical evidence ...Biogen Inc. (BIIB) closed at $272.63 in the latest trading session, marking a -1.55% move from the prior day. ... but the PEG ratio also takes into account the stock's expected earnings growth ...

138.99M. -77.03%. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...

Complete Biogen Inc. stock information by Barron's. View real-time BIIB stock price and news, along with industry-best analysis.

The drug could bring in $12.9 billion in sales by 2028, according to GlobalData forecasts. Today, Biogen's annual revenue has declined to about $10 billion from a peak of more than $14 billion, so ...See Biogen Inc. (BIIB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Biogen Inc (BIIB) stock has risen 2.66% while the S&P 500 has fallen -0.49% as of 11:16 AM on Wednesday, Apr 5. BIIB has gained $7.31 from the previous closing price of $275.25 on volume of 296,402 shares. Over the past year the S&P 500 is lower by -9.83% while BIIB has gained 36.10%. BIIB earned $20.87 a per share in the over the last 12 ...A recent study conducted by market analysts has shed light on the significant influence that Biogen Inc.’s stock performance has on the overall stock market. The study found that on Tuesday, despite a positive trading session, Biogen Inc.’s shares slipped by 0.60% to $227.41. This marked the second consecutive day of losses for the company.At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Learn more about Biogen Inc (BIIB.xnas). Get the latest share price information and trade with FP Markets.

Cambridge, Mass. – March 8, 2023 – Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) announced that the U.S. Food and Drug Administration (FDA) notified the companies that the agency does not currently plan to convene an advisory committee meeting to discuss the New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum ...Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily revenues …The largest individual shareholder of Apple, Inc. is Arthur D. Levinson, with over 1.1 million shares, as of late November 2014. Levinson is currently the non-executive Chairman of the Board of directors for Apple. He joined the Board in 20...With an impressive price tag of $370 thousand, the drug could generate up to $1 billion in sales. Nevertheless, Biogen will also aim to increase shareholder value …Nov 16, 2023 · Biogen Inc (NASDAQ: BIIB) has a higher price-to-earnings ratio of 22.83x compared to its average ratio, and the 36-month beta value for BIIB is at 0.07. Analysts have varying views on the stock, with 23 analysts rating it as a “buy,” 3 rating it as “overweight,” 8 as “hold,” and 0 as “sell.” The average […] The average Biogen stock price prediction forecasts a potential upside of 37.78% from the current BIIB share price of $234.64. What is BIIB's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BIIB ) forecast ROE is N/A , which is considered weak . Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (78.5%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (16.7%) ; - other (4.8%): primarily ...

Pursuant to the Biogen Idec Inc. 2017 Omnibus Equity Plan (as it may be amended from time to time, the “Plan”), Biogen Inc. (the “Company”) hereby grants to you, an employee of the Company or one of its Affiliates (the “Participant”), on each of the grant dates specified on your Fidelity stock plan account (the “Grant Date”), the number of market stock units …

Biogen-Sage Therapeutics postpartum depression pill priced at $15,900. Biogen and Sage Therapeutics' oral pill to treat postpartum depression (PPD) in adults is expected to cost U.S. wholesalers $15,900 for a full 14-day treatment, Sage Therapeutics said on Tuesday. Other symbols:Biogen-Sage Therapeutics postpartum depression pill priced at $15,900. Biogen and Sage Therapeutics' oral pill to treat postpartum depression (PPD) in adults is expected to cost U.S. wholesalers $15,900 for a full 14-day treatment, Sage Therapeutics said on Tuesday. Other symbols:Get Biogen Inc historical price data for BIIB stock. Investing.com has all the historical stock data including the closing price, open, high, low, change and % change.In biopharma, therapies to treat or prevent Alzheimer's disease constitute one such growth market. Let's survey the competitive landscape as it is today, and think through how it's likely to develop. Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest news headlines from Biogen Inc. Common Stock (BIIB) at Nasdaq.com.Biogen and Sage enter into an agreement to jointly develop and commercialize zuranolone and SAGE-324 in the U.S.; Biogen to receive exclusive license to develop and commercialize zuranolone and SAGE-324 outside of the U.S., excluding rights to zuranolone in Japan, Taiwan and South Korea; Sage Therapeutics to receive …

Oct 31, 2023 · Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.

A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, June 7, 2021. Biogen Inc. shares soared after its controversial Alzheimer's disease therapy was ...

Biogen Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time BIIB stock price.The drug could bring in $12.9 billion in sales by 2028, according to GlobalData forecasts. Today, Biogen's annual revenue has declined to about $10 billion from a peak of more than $14 billion, so ...Created with Sketch. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and ... Biogen Inc. (BIIB) Acquiree: Reata Pharmaceuticals, Inc. (RETA) Details: Biogen Inc. (NASDAQ:BIIB) - has completed the acquisition of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), a company focused on developing therapeutics that regulate cellular metabolism and inflammation in serious neurologic diseases.The average Biogen stock price prediction forecasts a potential upside of 37.78% from the current BIIB share price of $234.64. What is BIIB's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BIIB ) forecast ROE is N/A , which is considered weak .Evaluate the expected performance of Biogen Inc. (BIIB) for the quarter ended September 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. Biogen's (BIIB) sales in the third quarter are likely to have been hurt by ...Biogen Inc Stock , BIIB 231.95 + +% Pre-market 05:14:37 AM NAS Add to watchlist 231.95 +0.70 +0.30% Official Close 01:00:00 PM EDT 11/24/2023 NAS News Analyst Data …Sep. 29, 2023, 05:03 PM. (RTTNews) - Biogen Inc. (BIIB) announced that the U.S. Food and Drug Administration has approved Tofidence (tocilizumab-bavi) intravenous formulation, a biosimilar ...Insiders trading at Biogen Inc. Over the last 20 years, insiders at Biogen Inc have traded over $166,805,377 worth of Biogen Inc stock and bought 664,864 units worth $182,900,528 . The most active insiders traders include Adam Koppel, Alexander J Denner, and Stelios Papadopoulos.On average, Biogen Inc executives and independent …

Oct 11, 2023. Cambridge, Mass.— Biogen Inc . (Nasdaq:BIIB) today announced it will report third quarter 2023 financial results Wednesday, November 8, 2023, before the financial markets open. Following the release of the financials, the Company will host a live webcast with Biogen management at 8:00 a.m. ET.On today's stock market, Biogen stock dropped 3.5% to close at 275.07. Eisai stock fell 1.7% to 16.80. Biogen Stock: Medicare Coverage Is Key.Invisible Fence Inc. is a leading provider of innovative pet containment and lifestyle solutions. With over 40 years of experience, Invisible Fence Inc. has developed products that are designed to keep pets safe and secure in their own yard...Instagram:https://instagram. online stock broker canadaai waternyse tupday trading schools near me See Biogen Inc. (BIIB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Find the latest Eisai Co., Ltd. (4523.T) stock quote, history, news and other vital information to help you with your stock trading and investing. tappp betmgminsurance on engagement ring state farm Nov 28, 2023 · A recent study conducted by market analysts has shed light on the significant influence that Biogen Inc.’s stock performance has on the overall stock market. The study found that on Tuesday, despite a positive trading session, Biogen Inc.’s shares slipped by 0.60% to $227.41. This marked the second consecutive day of losses for the company. Complete Biogen Inc. stock information by Barron's. View real-time BIIB stock price and news, along with industry-best analysis. best stocks for under dollar10 Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. $88.70 +1.21 +1.38%. Plug Power, Inc. Common Stock. $9.46 -1.29. Biogen Inc ...Biogen Inc. (BIIB) closed the most recent trading day at $276.17, moving -0.8% from the previous trading session. This change lagged the S&P 500's 0.71% gain on the day. Meanwhile, the Dow gained ...Biogen Stock Performance. Shares of Biogen stock opened at $234.64 on Friday. The company has a current ratio of 1.68, a quick ratio of 1.09 and a debt-to-equity ratio of 0.47. The firm has a ...